All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
HRTX / Heron Therapeutics, Inc.
|
|
|
|
|
|
|
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
|
|
|
|
|
|
CRBP / Corbus Pharmaceuticals Holdings, Inc.
|
|
|
|
|
|
|
|
US62857M1053 / MyoKardia, Inc.
|
|
|
|
|
|
|
|
ABEO / Abeona Therapeutics Inc.
|
|
|
|
|
|
|
|
US0153511094 / Alexion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
AERI / Aerie Pharmaceuticals Inc
|
|
|
|
|
|
|
|
FOMX / Foamix Pharmaceuticals Ltd.
|
|
|
|
|
|
|
|
SELB / Selecta Biosciences Inc
|
|
|
|
|
|
|
|
NERV / Minerva Neurosciences, Inc.
|
|
|
|
|
|
|
|
MGNX / MacroGenics, Inc.
|
|
|
|
|
|
|
|
CYCCP / Cyclacel Pharmaceuticals, Inc. - Preferred Stock
|
|
|
|
|
|
|
|
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
AGLE / Aeglea BioTherapeutics Inc
|
|
|
|
|
|
|
|
SGEN / Seagen Inc
|
|
|
|
|
|
|
|
IDRA / Idera Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
HALO / Halozyme Therapeutics, Inc.
|
|
|
|
|
|
|
|
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
MDGN / Medgenics, Inc.
|
|
|
|
|
|
|
|
CFRX / ContraFect Corp
|
|
|
|
|
|
|
|
TNXP / Tonix Pharmaceuticals Holding Corp.
|
|
|
|
|
|
|
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
TRIL / Trillium Therapeutics Inc
|
|
|
|
|
|
|
|
SGMO / Sangamo Therapeutics, Inc.
|
|
|
|
|
|
|
|
NTLA / Intellia Therapeutics, Inc.
|
|
|
|
|
|
|
|
MDGL / Madrigal Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
INSM / Insmed Incorporated
|
|
|
|
|
|
|
|
INCY / Incyte Corporation
|
|
|
|
|
|
|
|
451731103 / Ignyta, Inc.
|
|
|
|
|
|
|
|
AVXS / AveXis, Inc.
|
|
|
|
|
|
|
|
FSTX / F-star Therapeutics Inc
|
|
|
|
|
|
|
|
BDSI / Biodelivery Sciences International
|
|
|
|
|
|
|
|
FMI / Foundation Medicine, Inc.
|
|
|
|
|
|
|
|
BTX.WS / BioTime, Inc. Warrants exp. 2018-10-01
|
|
|
|
|
|
|
|
ABBV / AbbVie Inc.
|
|
|
|
|
|
|
|
SCYX / SCYNEXIS, Inc.
|
|
|
|
|
|
|
|
PTN / Palatin Technologies, Inc.
|
|
|
|
|
|
|
|
JUNO / Juno Therapeutics, Inc.
|
|
|
|
|
|
|
|
OSIR / Osiris Therapeutics, Inc.
|
|
|
|
|
|
|
|
BIIB / Biogen Inc.
|
|
|
|
|
|
|
|
74365AAB7 / Protalix BioTherapeutics, Inc. Bonds 4.5% 9/15/18
|
|
|
|
|
|
|
|
STML / Stemline Therapeutics, Inc.
|
|
|
|
|
|
|
|
09061GAD3 / BioMarin Pharmaceutical Inc. Bond 1.875% 4/23/2017
|
|
|
|
|
|
|
|
US670002AB05 / Novavax, Inc. Bond 3.75% Due 2/1/2023
|
|
|
|
|
|
|
|
EXEL / Exelixis, Inc.
|
|
|
|
|
|
|
|
GLYC / GlycoMimetics, Inc.
|
|
|
|
|
|
|
|
APTO / Aptose Biosciences Inc.
|
|
|
|
|
|
|
|
DERM / Journey Medical Corporation
|
|
|
|
|
|
|
|
TMBR / Timber Pharmaceuticals Inc
|
|
|
|
|
|
|
|
ALDR / Alder BioPharmaceuticals, Inc.
|
|
|
|
|
|
|
|
04269XAA3 / Array BioPharma Inc. Bonds 3.0% 6/1/2020
|
|
|
|
|
|
|
|
AAAP / Advanced Accelerator Applications S.A
|
|
|
|
|
|
|
|
DMTX / Dimension Therapeutics, Inc.
|
|
|
|
|
|
|
|
US00767EAB83 / Aegerion Pharmaceuticals, Inc. 2.0% Bond due 2019-08-15
|
|
|
|
|
|
|
|
ONCE / Spark Therapeutics, Inc.
|
|
|
|
|
|
|
|
MDWD / MediWound Ltd.
|
|
|
|
|
|
|
|
NDRM / NeuroDerm Ltd.
|
|
|
|
|
|
|
|
45780VAB8 / Inotek Pharmaceuticals Corporation Bonds 5.75% 8/1/2021
|
|
|
|
|
|
|
|
IMDZ / Immune Design Corp.
|
|
|
|
|
|
|
|
LGND / Ligand Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
CNCE / Concert Pharmaceuticals Inc
|
|
|
|
|
|
|
|
PRQR / ProQR Therapeutics N.V.
|
|
|
|
|
|
|
|
CLCD / CoLucid Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
GHDX / Genomic Health, Inc.
|
|
|
|
|
|
|
|
BIVV / Bioverativ Inc.
|
|
|
|
|
|
|
|
QURE / uniQure N.V.
|
|
|
|
|
|
|
|
ADMS / Adamas Pharmaceuticals Inc
|
|
|
|
|
|
|
|
ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
JNCE / Jounce Therapeutics Inc
|
|
|
|
|
|
|
|
ASMB / Assembly Biosciences, Inc.
|
|
|
|
|
|
|
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
NVIV / InVivo Therapeutics Holdings Corp.
|
|
|
|
|
|
|
|
NBRV / Nabriva Therapeutics Plc
|
|
|
|
|
|
|
|
CLLS / Cellectis S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ZGNX / Zogenix Inc
|
|
|
|
|
|
|
|
WINT / Windtree Therapeutics, Inc.
|
|
|
|
|
|
|
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
|
|
|
|
|
|
ARCT / Arcturus Therapeutics Holdings Inc.
|
|
|
|
|
|
|
|
ABUS / Arbutus Biopharma Corporation
|
|
|
|
|
|
|
|
EPZM / Epizyme Inc
|
|
|
|
|
|
|
|
RIGL / Rigel Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
0HBB / Aimmune Therapeutics Inc
|
|
|
|
|
|
|
|
ARAV / Aravive, Inc.
|
|
|
|
|
|
|
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
IONS / Ionis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
09061GAE1 / BioMarin Pharmaceutical Inc. Bond 0.75% 10/15/2018
|
|
|
|
|
|
|
|
MCRB / Seres Therapeutics, Inc.
|
|
|
|
|
|
|
|
/ Achaogen Inc
|
|
|
|
|
|
|
|
ITCI / Intra-Cellular Therapies, Inc.
|
|
|
|
|
|
|
|
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
CMRX / Chimerix, Inc.
|
|
|
|
|
|
|
|
INFI / Infinity Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
RARX / Ra Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
LOXO / Loxo Oncology, Inc.
|
|
|
|
|
|
|
|
US00484MAA45 / Acorda Therapeutics, Inc. Bond 1.750% 6/1
|
|
|
|
|
|
|
|
/ Array BioPharma, Inc.
|
|
|
|
|
|
|
|
AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
SYRS / Syros Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ANAB / AnaptysBio, Inc.
|
|
|
|
|
|
|
|
BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
KPTI / Karyopharm Therapeutics Inc.
|
|
|
|
|
|
|
|
FLGT / Fulgent Genetics, Inc.
|
|
|
|
|
|
|
|
ALDX / Aldeyra Therapeutics, Inc.
|
|
|
|
|
|
|
|
LJPC / La Jolla Pharmaceutical Co.
|
|
|
|
|
|
|
|
QLGN / Qualigen Therapeutics, Inc.
|
|
|
|
|
|
|
|
SRRA / Sierra Oncology Inc
|
|
|
|
|
|
|
|
DSCI / Derma Sciences, Inc.
|
|
|
|
|
|
|
|
ACOR / Acorda Therapeutics, Inc.
|
|
|
|
|
|
|
|
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
CCXI / ChemoCentryx Inc
|
|
|
|
|
|
|
|
TENX / Tenax Therapeutics, Inc.
|
|
|
|
|
|
|
|
XNCR / Xencor, Inc.
|
|
|
|
|
|
|
|
TARA / Protara Therapeutics, Inc.
|
|
|
|
|
|
|
|
SAGE / Sage Therapeutics, Inc.
|
|
|
|
|
|
|
|
ENTA / Enanta Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
TRVN / Trevena, Inc.
|
|
|
|
|
|
|
|
VIRX / Viracta Therapeutics, Inc.
|
|
|
|
|
|
|
|
NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
DVAX / Dynavax Technologies Corporation
|
|
|
|
|
|
|
|
RARE / Ultragenyx Pharmaceutical Inc.
|
|
|
|
|
|
|
|
XLRN / Acceleron Pharma Inc
|
|
|
|
|
|
|
|
AGIO / Agios Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CBAY / CymaBay Therapeutics, Inc.
|
|
|
|
|
|
|
|
CERS / Cerus Corporation
|
|
|
|
|
|
|
|
IMGN / ImmunoGen, Inc.
|
|
|
|
|
|
|
|
AFMD / Affimed N.V.
|
|
|
|
|
|
|
|
NTRA / Natera, Inc.
|
|
|
|
|
|
|
|
BLUE / bluebird bio, Inc.
|
|
|
|
|
|
|
|
MRUS / Merus N.V.
|
|
|
|
|
|
|
|
ALKS / Alkermes plc
|
|
|
|
|
|
|
|
NVTA / Invitae Corporation
|
|
|
|
|
|
|
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|